生脉注射液治疗慢性肺心病急性发作40例临床疗效观察

Clinical Observation of Shengmai Injection for the Treatment of 40 Cases of Patients Chronic Pulmonary Heart Disease

目的探析慢性肺心病急性发作期采取生脉注射液治疗的临床效果。方法选取我院2014年6月~2015年12月收治的80例慢性肺心病患者,将其随机分为治疗组和对照组,各为40例,治疗组采取生脉注射液,对照组采取常规西医治疗,比例两组治疗效果及心功能改善情况。结果治疗组心功能改善总有效率82.5%与对照组比较差异明显,P〈0.05;治疗后两组Pa O2、Pa CO2均较治疗前改善,且治疗组显著优于对照组,P〈0.05。结论慢性肺心病急性发作期采取生脉注射液治疗,疗效较好,改善患者心功能。

Objective Analysis of acute exacerbation of chronic pulmonary heart disease take the clinical effect of Shengmai Injection treatment.Methods Our hospital in June 2014 to December 2015 were treated 80 cases of patients with chronic pulmonary heart disease were randomly divided into treatment group and the control group,40 cases,the treatment group received Shengmai injection,the control group received conventional Western treatment,the proportion of treatment groups and heart function improvement.Results Treatment group the total efficiency of cardiac function improved 82.5% compared with control group significant difference,P〈0.05; before and after treatment groups PaO_2,PaCO_2 improved than before treatment,and the treatment group was significantly better than the control group,P〈0.05.Conclusion Acute exacerbation of chronic pulmonary heart disease take Shengmai Injection treatment,good effect,improve cardiac function,worthy of promotion.